IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple MyelomaByKennedy Ferruggia, Assistant Editor,Claudio Cerchione, MD, PhDSeptember 18th 2025An expert discusses the benefits of anti-CD38 quadruplet regimens for elderly multiple myeloma patients.